1. Home
  2. CCBG vs ACHV Comparison

CCBG vs ACHV Comparison

Compare CCBG & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capital City Bank Group

CCBG

Capital City Bank Group

HOLD

Current Price

$51.05

Market Cap

828.1M

Sector

Finance

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$7.15

Market Cap

726.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCBG
ACHV
Founded
1895
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
828.1M
726.5M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
CCBG
ACHV
Price
$51.05
$7.15
Analyst Decision
Hold
Strong Buy
Analyst Count
3
12
Target Price
★ $51.83
$14.15
AVG Volume (30 Days)
68.0K
★ 1.3M
Earning Date
10-20-2026
11-09-2026
Dividend Yield
★ 2.13%
N/A
EPS Growth
★ 15.38
N/A
EPS
★ 0.92
N/A
Revenue
N/A
N/A
Revenue This Year
$1.18
N/A
Revenue Next Year
$3.29
N/A
P/E Ratio
$55.17
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.55
$2.62
52 Week High
$53.60
$8.64

Technical Indicators

Market Signals
Indicator
CCBG
ACHV
Relative Strength Index (RSI) 61.01 52.90
Support Level $47.63 $6.92
Resistance Level $51.04 $7.48
Average True Range (ATR) 0.95 0.35
MACD 0.30 0.05
Stochastic Oscillator 82.13 76.18

Price Performance

Historical Comparison
CCBG
ACHV

About CCBG Capital City Bank Group

Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services, among others, through its banking offices in Florida, Georgia, and Alabama.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: